LSA
TEVA icon

Leonteq Securities AG’s Teva Pharmaceuticals TEVA Stock Holding History

Leonteq Securities AG’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Sell
1,063
-5,084
-83% -$169K ﹤0.01% 866
2026
Q1 		$185K Buy
6,147
+4,061
+195% +$131K 0.01% 616
2025
Q4 		$65.1K Sell
2,086
-12,600
-86% -$310K ﹤0.01% 905
2025
Q3 		$297K Sell
14,686
-19,349
-57% -$340K 0.01% 525
2025
Q2 		$570K Sell
34,035
-43,062
-56% -$695K 0.02% 362
2025
Q1 		$1.19M Buy
77,097
+75,961
+6,687% +$1.36M 0.07% 216
2024
Q4 		$25K Sell
1,136
-270
-19% -$4.91K ﹤0.01% 939
2024
Q3 		$25.3K Sell
1,406
-3,534
-72% -$61.9K ﹤0.01% 883
2024
Q2 		$80.3K Sell
4,940
-49,717
-91% -$766K 0.01% 665
2024
Q1 		$771K Sell
54,657
-225,770
-81% -$2.85M 0.06% 254
2023
Q4 		$2.93M Sell
280,427
-46,744
-14% -$436K 0.17% 122
2023
Q3 		$3.34M Sell
327,171
-72,960
-18% -$679K 0.18% 122
2023
Q2 		$3.01M Buy
400,131
+114,220
+40% +$926K 0.16% 148
2023
Q1 		$2.53M Buy
+285,911
New +$2.83M 0.12% 158
2022
Q4 		– Sell
-31,762
Closed -$277K – 1358
2022
Q3 		$256K Sell
31,762
-97,063
-75% -$858K 0.01% 483
2022
Q2 		$969K Sell
128,825
-92,932
-42% -$810K 0.04% 288
2022
Q1 		$2.08M Buy
221,757
+14,491
+7% +$121K 0.07% 196
2021
Q4 		$1.66M Sell
207,266
-74,934
-27% -$676K 0.06% 250
2021
Q3 		$2.75M Buy
282,200
+177,903
+171% +$1.67M 0.12% 149
2021
Q2 		$1.03M Buy
104,297
+39,512
+61% +$418K 0.06% 262
2021
Q1 		$748K Sell
64,785
-59,246
-48% -$679K 0.04% 317
2020
Q4 		$1.2M Buy
+124,031
New +$1.19M 0.06% 244

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Leonteq Securities AG's TEVA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Teva Pharmaceuticals (TEVA) stake by 83% in Q2 2026, selling an estimated $169K and leaving 1,063 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Leonteq Securities AG first reported a position in TEVA in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.34M in Q3 2023. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Leonteq Securities AG held 1,063 shares of Teva Pharmaceuticals worth $36K as of Q2 2026.
  • Leonteq Securities AG sold 5,084 Teva Pharmaceuticals shares in Q2 2026, an estimated $169K.
  • Teva Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #866 holding.
  • Leonteq Securities AG first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Teva Pharmaceuticals position peaked at $3.34M in Q3 2023.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.